Patents by Inventor Samuel J. Flanders

Samuel J. Flanders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190134306
    Abstract: An anti-coagulant maintenance system for use in the treatment of patients with deep-vein thrombosis (DVT), pulmonary embolism (PE), Acute Coronary Syndrome, need for prophylactic anticoagulation or another related condition. The system establishes and adjusts the dosing of an anti-coagulant based upon periodic blood testing of a system specified frequency. Warning or alert messages or signals are produced if blood tests are not performed and a dosage adjustment is made based upon a coagulation test result outside of an established normal range. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Application
    Filed: October 12, 2018
    Publication date: May 9, 2019
    Applicant: Indiana University Health, Inc.
    Inventor: Samuel J. Flanders
  • Publication number: 20180117250
    Abstract: A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Application
    Filed: December 20, 2017
    Publication date: May 3, 2018
    Applicant: Indiana University Health, Inc.
    Inventor: Samuel J. Flanders
  • Publication number: 20160310668
    Abstract: A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Application
    Filed: July 7, 2016
    Publication date: October 27, 2016
    Inventor: Samuel J. Flanders
  • Publication number: 20160296698
    Abstract: An anti-coagulant maintenance system for use in the treatment of patients with deep-vein thrombosis (DVT), pulmonary embolism (PE), Acute Coronary Syndrome, need for prophylactic anticoagulation or another related condition. The system establishes and adjusts the dosing of an anti-coagulant based upon periodic blood testing of a system specified frequency. Warning or alert messages or signals are produced if blood tests are not performed and a dosage adjustment is made based upon a coagulation test result outside of an established normal range. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Application
    Filed: June 17, 2016
    Publication date: October 13, 2016
    Inventor: Samuel J. Flanders
  • Publication number: 20090099438
    Abstract: A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Application
    Filed: December 17, 2008
    Publication date: April 16, 2009
    Inventor: Samuel J. Flanders
  • Patent number: 7509156
    Abstract: A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: March 24, 2009
    Assignee: Clarian Health Partners, Inc.
    Inventor: Samuel J. Flanders
  • Publication number: 20080194516
    Abstract: An anti-coagulant maintenance system for use in the treatment of patients with deep-vein thrombosis (DVT), pulmonary embolism (PE), Acute Coronary Syndrome, need for prophylactic anticoagulation or another related condition. The system establishes and adjusts the dosing of an anti-coagulant based upon periodic blood testing of a system specified frequency. Warning or alert messages or signals are produced if blood tests are not performed and a dosage adjustment is made based upon a coagulation test result outside of an established normal range. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Application
    Filed: November 2, 2007
    Publication date: August 14, 2008
    Inventor: Samuel J. Flanders